Pharma-Bio Serv Q2 net income rises to $0.4M; revenue falls 8% to $4.6M

Pharma-Bio Serv, Inc.

Revenue for three months ended Apr 30, 2023: $4.6M, down $0.4M YoY.
Net income for Q2 was $0.4M, up $0.2M from prior year; H1 net income $0.8M, up $0.3M.
Gross profit margin improved 5.0 percentage points in Q2 and 4.8 ppts in H1.
CEO cites strategy to focus on most profitable markets and grow presence.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Pharma-Bio Serv, Inc. reported the three and six months ended April 30, 2023 results: revenue approximately $4.6 and $8.8 million, respectively, net income approximately $0.4 and $0.8 million, respectively.

Period: the three and six months ended April 30, 2023
Revenue: approximately $4.6 and $8.8 million, respectively
Net income: approximately $0.4 and $0.8 million, respectively
Result: reported results

Exact text from the filing

revenues for the three and six months ended April 30, 2023 were approximately $4.6 and $8.8 million, respectively, a decrease of approximately $0.4 and $1.2 million, respectively, when compared to the same periods last year.

View on SEC.gov

310 earnings releases filed in the last 30 days. Browse all earnings releases →

Pharma-Bio Serv, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-23-008031

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.